Search results for "sensi"

showing 10 items of 5553 documents

Sensitivity and specificity of the mood disorder questionnaire and the bipolar spectrum diagnostic scale in Argentinean patients with mood disorders

2010

Abstract Objective To assess the sensitivity and specificity of two self-report instruments for detection of bipolarity in a sample of Argentinean patients. Method Spanish versions of the MDQ and the BSDS were administered over four months at 11 sites in Argentina. Diagnoses were made using DSM-IV criteria and the MINI. The study sample consisted of patients diagnosed with Bipolar Disorder (BD) Types I, II, or NOS. BDNOS diagnoses were made using extended guidelines for bipolar spectrum symptoms. Unipolar patients were used as a control group. Of 493 patients screened, 354 completed evaluation by MDQ and MINI, and 363 by BSDS and MINI. Results Specificity of MDQ was 0.97 and BSDS was 0.81. …

AdultMaleBipolar DisorderAdolescentPsychometricsPsychometricsArgentinaSensitivity and SpecificityPrevalence of mental disordersSurveys and QuestionnairesOutpatientsmental disordersmedicineHumansBipolar disorderMedical diagnosisAgedPsychiatric Status Rating ScalesBipolar spectrum diagnostic scaleMood DisordersNot Otherwise SpecifiedMood Disorder QuestionnaireMiddle AgedWeights and Measuresmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologyMood disordersFemalePsychologyClinical psychologyJournal of Affective Disorders
researchProduct

Screening for Autoantibodies to Tissue Transglutaminase Reveals a Low Prevalence of Celiac Disease in Blood Donors with Cryptogenic Hypertransaminase…

2001

Patients with chronic cryptogenic hypertransaminasemia are at high risk of developing celiac disease (CD). In fact, among the various serological disorders, CD patients at onset frequently present hypertransaminasemia. In this study, we evaluated usefulness and reliability of the new test for antitissue transglutaminase (tTG) in screening for CD as well as in estimating the prevalence of CD in a population of blood donors presenting unexplained hypertransaminasemia at donation. Controls were 180 consecutive healthy donors without hypertransaminasemia and 20 CD patients with known antiendomysial antibody (EmA) positivity. Out of 22,204 blood donors over a period of 2 years, we found 258 subj…

AdultMaleBlood donormedicine.medical_specialtyTissue transglutaminasePopulationE2F6 Transcription FactorBlood DonorsEnzyme-Linked Immunosorbent AssaySensitivity and SpecificityGastroenterologyCoeliac diseaseSerologyIntestinal mucosaInternal medicineImmunopathologyBiopsyPrevalencemedicineHumansCeliac diseaseIntestinal MucosaFluorescent Antibody Technique IndirecteducationTransaminasesAutoantibodieseducation.field_of_studyTransglutaminasesbiologymedicine.diagnostic_testbusiness.industryGastroenterologyAutoantibodyReproducibility of ResultsMiddle Agedmedicine.diseaseTransglutaminaseRepressor ProteinsImmunologybiology.proteinFemalebusinessTranscription FactorsDigestion
researchProduct

Use of the Distress Thermometer in Cancer Survivors: Convergent Validity and Diagnostic Accuracy in a Spanish Sample

2019

Objectives To explore the performance of the National Comprehensive Cancer Network Distress Thermometer (DT) as a distress screening tool in cancer survivors. Sample & setting 236 Spanish adult-onset cancer survivors who visited the Fundacion Instituto Valenciano de Oncologia in Valencia, Spain, for follow-up appointments. Methods & variables Survivors completed the DT and the Brief Symptom Inventory 18 (BSI-18), which has established a cutoff score for identifying clinically significant distress. Results Receiver operating characteristic curve analysis of the DT scores relative to the BSI-18 cutoff score showed good overall accuracy. For a score of 5 or greater, sensitivity, specificity, p…

AdultMaleBrief Symptom Inventory 18PsychometricsDiagnostic accuracySample (statistics)Sensitivity and SpecificityCancer SurvivorsmedicineHumansDistress ThermometerTranslationsAgedAged 80 and overReceiver operating characteristicbusiness.industryCancerMiddle Agedmedicine.diseaseDistressConvergent validitySpainFemalebusinessStress PsychologicalClinical psychologyOncology Nursing Forum
researchProduct

Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene

2009

Abstract Background Polymorphisms of cytochrome P450 2D6 (CYP2D6) have a significant effect on the pharmacokinetics of most tricyclic antidepressants. More than 150 alleles lead to four distinct phenotypes of drug metabolism. The phenotypes are described as ultrarapid, extensive, intermediate, and poor metabolizers. Therapeutic plasma levels of CYP2D6 substrates may be difficult to achieve. Here we describe a rapid and reliable procedure for CYP2D6*4, *3, *6, and *9 genotyping. Design and methods Serum concentrations of venlafaxine and its pharmacologically active metabolite, O-desmethylvenlafaxine, were measured in patients treated with the antidepressant venlafaxine, a substrate of CYP2D6…

AdultMaleCYP2D6GenotypeDNA Mutational AnalysisMolecular Sequence DataClinical BiochemistrySingle-nucleotide polymorphismBiologyPolymerase Chain ReactionSensitivity and Specificitydigestive systemGene DuplicationGene duplicationGenotypeHumansAlleleskin and connective tissue diseasesGeneGenotypingAllelesSequence DeletionGeneticsPolymorphism GeneticBase SequenceDepressionVenlafaxine HydrochlorideReproducibility of ResultsSequence Analysis DNAGeneral MedicineMiddle AgedCyclohexanolsMolecular biologyReal-time polymerase chain reactionCytochrome P-450 CYP2D6MutationAntidepressive Agents Second-GenerationFemaleClinical Biochemistry
researchProduct

Clinical evaluation of pancreatitis-associated protein as a serum marker of hepatocellular carcinoma: Comparison with α-fetoprotein

1998

This study evaluated the significance of serum pancreatitis-associated protein (PAP) assay, as a marker of hepatocellular carcinoma (HCC), in comparison and combined with α-fetoprotein (AFP) assay. Sixty-five patients with HCC, 59 with liver cirrhosis (LC) and 68 asymptomatic controls (C) were studied. PAP and AFP values significantly increased from C to LC and HCC group (p < 0.0001). The area under receiver-operating characteristic (ROC) curve for the two markers was not statistically different. At 100% specificity, ROC analysis gave a cut-off level for AFP of 166 IU/l with 40% sensitivity, and a cut-off level of 240 µg/l for PAP with 23% sensitivity. Diagnostic accuracy of combined AFP…

AdultMaleCancer ResearchPathologymedicine.medical_specialtyCirrhosisCarcinoma HepatocellularPancreatitis-Associated ProteinsAsymptomaticSensitivity and SpecificityAntigens NeoplasmBiomarkers TumorMedicineHumansLectins C-TypeneoplasmsTumor markerAgedbusiness.industryLiver NeoplasmsGeneral MedicineMiddle Agedmedicine.diseasedigestive system diseasesLogistic ModelsOncologyHepatocellular carcinomaPancreatitisFemalealpha-Fetoproteinsmedicine.symptombusinessClinical evaluationSerum markersAcute-Phase Proteins
researchProduct

Prospective, blinded comparison of cytology and DNA-image cytometry of brush biopsies for early detection of oral malignancy

2012

summary Objectives: Adjunctive techniques like DNA image cytometry (DNA-ICM) have been attributed to enhance the diagnostic performance of oral brush biopsies. The aim of the study was an evaluation of brush biopsies, analysed according to morphological criteria and by DNA-ICM vs. histological findings in a blinded prospective trial. Materials and methods: Eighty eight brush biopsies of 70 patients were sampled. Only clinical suspicious but not evident malignant oral lesions were included. Clinical diagnosis was leukoplakia (n = 36), lichen planus (n = 18), verruciform erythroplakia (n = 12), erythroleukoplakia (n = 9), erosion (n = 7) and induration (n = 6). Evaluation was conducted via hi…

AdultMaleCancer ResearchPathologymedicine.medical_specialtyCytodiagnosisMalignancySensitivity and SpecificityCytologyOral and maxillofacial pathologyImage Processing Computer-AssistedmedicineCarcinomaHumansSingle-Blind MethodProspective StudiesFalse Negative ReactionsMouth FloorEarly Detection of CancerAgedImage CytometryLeukoplakiaAged 80 and overErythroplakiaPloidiesbusiness.industryMouth MucosaHistologyDNA NeoplasmMiddle Agedmedicine.diseaseTongue Neoplasmsstomatognathic diseasesOncologyDysplasiaErythroplasiaCarcinoma Squamous CellFemaleMouth NeoplasmsLeukoplakia OralOral SurgerybusinessPrecancerous ConditionsCarcinoma in SituLichen Planus OralOral Oncology
researchProduct

A Putatively Functional Haplotype in the Gene Encoding Transforming Growth Factor Beta-1 as a Potential Biomarker for Radiosensitivity

2011

Purpose To determine whether genetic variability in TGFB1 is related to circulating transforming growth factor-β1 (TGF-β1) plasma concentrations after radiotherapy and to radiosensitivity of lymphoid cells. Patients and Methods Transforming growth factor-β1 plasma concentrations ( n = 79) were measured in patients 1 year after radiotherapy and chromosomal aberrations ( n = 71) ex vivo before therapy start. Furthermore, TGF-β1 secretion and apoptosis were measured in isolated peripheral blood mononuclear cells of 55 healthy volunteers. These phenotypes were analyzed in relation to five germline polymorphisms in the 5′ region of the TGFB1 gene. Because of high linkage disequilibrium, these fi…

AdultMaleCancer ResearchSomatic cellDNA damageApoptosisPolymorphism Single NucleotideRadiation TolerancePeripheral blood mononuclear cellLinkage DisequilibriumCell LineTransforming Growth Factor beta103 medical and health sciences0302 clinical medicineHumansMedicineRadiology Nuclear Medicine and imagingRadiosensitivityGeneMicronuclei Chromosome-DefectiveAged030304 developmental biologyAged 80 and over0303 health sciencesRadiationbiologybusiness.industryHaplotypeTransforming growth factor betaMiddle AgedMolecular biology3. Good healthHaplotypesOncology030220 oncology & carcinogenesisMicronucleus testImmunologyLeukocytes Mononuclearbiology.proteinFemalebusinessBiomarkersDNA DamageInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

Sensing gastric cancer via point‐of‐care sensor breath analyzer

2021

Background Detection of disease by means of volatile organic compounds from breath samples using sensors is an attractive approach to fast, noninvasive and inexpensive diagnostics. However, these techniques are still limited to applications within the laboratory settings. Here, we report on the development and use of a fast, portable, and IoT-connected point-of-care device (so-called, SniffPhone) to detect and classify gastric cancer to potentially provide new qualitative solutions for cancer screening. Methods A validation study of patients with gastric cancer, patients with high-risk precancerous gastric lesions, and controls was conducted with 2 SniffPhone devices. Linear discriminant an…

AdultMaleCancer ResearchValidation studymedicine.medical_specialtyvolatile organic compoundPoint-of-Care SystemsBiosensing TechniquesSensitivity and Specificity03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingbreath analyzerStomach NeoplasmsCancer screeningmedicineHumansNanotechnology030212 general & internal medicinePoint of careAgedAged 80 and overbusiness.industrygastric cancerscreeningCancerpersonalizedDiscriminant AnalysisGastric lesionsMiddle Agedmedicine.diseaseLinear discriminant analysisprecancerous lesion3. Good healthBreath analyzerOncologyBreath Tests030220 oncology & carcinogenesisArea Under CurveCase-Control Studies/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemaleRadiologyInternet of ThingsbusinessPrecancerous ConditionsCancer
researchProduct

Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis

2009

AbstractWe performed a pooled analysis of data on atopic disease and risk of non–Hodgkin lymphoma (NHL) from 13 case-control studies, including 13,535 NHL cases and 16,388 controls. Self-reported atopic diseases diagnosed 2 years or more before NHL diagnosis (cases) or interview (controls) were analyzed. Pooled odds ratios (OR) and 95% confidence intervals (95% CI) were computed in two-stage random-effects or joint fixed-effects models, and adjusted for age, sex, and study center. When modeled individually, lifetime history of asthma, hay fever, specific allergy (excluding hay fever, asthma, and eczema), and food allergy were associated with a significant reduction in NHL risk, and there wa…

AdultMaleCancer Researchmedicine.medical_specialtyAllergyAdolescentCutaneous lymphomaArticleAtopyYoung AdultMeta-Analysis as Topicimmune system diseasesRisk FactorsInternal medicinehemic and lymphatic diseasesmedicineHypersensitivityHumansRisk factorAsthmaAgedAged 80 and overbusiness.industryLymphoma Non-HodgkinOdds ratioMiddle Agedmedicine.diseaseNon-Hodgkin's lymphomaOncologyCase-Control StudiesImmunologyHay feverFemalebusiness
researchProduct

Interleukin 3 in the treatment of chemotherapy induced thrombocytopenia.

1998

We enrolled 19 cancer patients (11 females, 8 males) with thrombocytopenia after standard dose of chemotherapy to receive IL3 10 mg/kg/day s.c. until hematologic recovery. Therapeutic success was obtained in 69.6% of cycles; a major response in 39.3% and a minor response in 30.3% of cycles. We obtained the best results in case of platelet count <49,000/mm3. The main toxicity was a flu-like syndrome. In two cycles (6%) we registered allergic episodes with flushing and lipothymia. In the 47% of cycles evaluable for toxicity no side effect was registered.

AdultMaleCancer Researchmedicine.medical_specialtySide effectmedicine.medical_treatmentAntineoplastic AgentsGastroenterologyDrug HypersensitivityInternal medicineNeoplasmsmedicineHumansPlateletInterleukin 3AgedChemotherapybusiness.industryCancerGeneral MedicineImmunotherapyMiddle Agedmedicine.diseaseThrombocytopeniaSurgeryClinical trialOncologyToxicityFemaleInterleukin-3businessOncology reports
researchProduct